RPMI-1640 and penicillin-streptomyocin (P/S) from Invitrogen (Carlsbad, CA). Human AB serum and fetal bovine serum (FBS) from Mediatech (Tewksbury, MA).
HEPES solution from Fisher Scientific (Fair Lawn, NJ).
Dantrolene sodium salt,
serotonin hydrochloride,
isoproterenol hydrochloride,
NKH 477,
forskolin and
phorbol 12-myristate 13-acetate (PMA) from Tocris Biosciences (Minneapolis, MN).
isoproterenol hydrochloride from R&D Systems (Minneapolis MN). Dopamine and H89 dihydrochloride from Sigma-Aldrich (St. Louis, MO).
3-Isobutyl-1-methylxanthine (IBMX) from MP Biomedicals (Santa Ana, CA).
RO-20-1724 from EMD Millipore (Temecula, CA).
YM-254,890 from Focus Biomolecules (Plymouth Meeting, PA). Dopamine and the beta-adrenergic receptor agonist Isoproterenol were resuspended in distilled H
2O to make stock concentrations of 10 mM, then diluted into media as needed.
RO-20-1724 (200 mM), IBMX (100 mM),
forskolin (10 mM),
YM-254,890 (10 mM) and PMA (100 μM) were resuspended in DMSO to the indicated concentrations, then diluted into media as indicated. Human macrophage colony stimulating factor (
M-CSF) was from Peprotech (Rocky Hill, NJ) and resuspended in 100 μL distilled H
2O.
Nickoloff E.A., Mackie P., Runner K., Matt S.M., Khoshbouei H, & Gaskill P.J. (2019). Dopamine increases HIV entry into macrophages by increasing calcium release via an alternative signaling pathway. Brain, behavior, and immunity, 82, 239-252.